← Eichor
Study identifier: NCT06913998 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

Condition: Inflammatory Bowel Diseases · Neutropenia · Nudt15 Deficiency  ·  Sponsor: National Taiwan University Hospital

PhaseN/A
Planned participants65
Who can joinAll sexes, 1 Year to 25 Years
Healthy volunteersNo

About this study

The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.

This description comes directly from the study's public registry record.

Talk to the study team

Wei-Ting Chen, MD  ·  +886-2-2312-3456  ·  DBE98@tepch.gov.tw

Jia-Feng Wu, MD, PhD  ·  +886-2-2312-3456  ·  wjf@ntu.edu.tw

Always discuss trial participation with your own doctor first.

Locations (1)

National Taiwan University HospitalTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06913998